Hillrom to use existing credit facilities for Bardy acquisition

By Sara Rosenberg

New York, Jan. 19 – Hillrom plans to use borrowings under its existing credit facilities to help fund the purchase of Bardy Diagnostics Inc., according to a news release.

Other funds for the $375 million acquisition will come from cash on hand.

Closing is expected in the company’s fiscal second quarter of 2021, subject to customary conditions.

Hillrom is a Chicago-based medical technology company. Bardy Diagnostics is a Seattle-based provider of ambulatory cardiac monitoring technologies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.